Management
The company was founded by Professors Douglas S. Clark and Jonathan S. Dordick. Drs. Dordick and Clark are leaders in the field of biocatalysis with particular expertise in drug discovery. Together they have nearly 40 years of biocatalysis, cell culture, bioengineering, and drug discovery related research experience. In a prior venture (EnzyMed, Inc.), Drs. Clark and Dordick successfully converted their academic research to commercial product development.
David Rozzell, Ph.D.
President and Chief Executive Officer
David Rozzell is the President and CEO of Solidus Biosciences. Dr. Rozzell has more than 25 years' of experience working in the field of biocatalysis and enzyme technology, including pioneering the creation of a broad range of Enzyme Screening Sets and the development and launch of the first Human Cytochrome Biocatalyst product line for drug metabolite synthesis. Previously, he was the Founder and CEO of BioCatalytics, Inc., a leading developer of enzymes and related technology for chemical synthesis, and joined Codexis, Inc. as VP, Biocatalysis Technology and Applications following the acquisition of BioCatalytics, Inc. by Codexis in July 2007. Dr. Rozzell has authored numerous scientific articles, spoken widely at international symposia, and is the inventor on more than 20 issued US patents. He received a PhD in Chemistry from Harvard University and a BS in Chemistry from the University of Virginia.
Douglas Clark, Ph.D.
Cofounder and Technical Adviser
Douglas S. Clark is a Professor of Chemical Engineering at the University of California, Berkeley. He received his B.S. in Chemistry from the University of Vermont in 1979 and his Ph.D. in Chemical Engineering from the California Institute of Technology in 1983. From 1984 to 1986 he was an Assistant Professor of Chemical Engineering at Cornell University. Professor Clark is currently the Editor-in-Chief of Biotechnology and Bioengineering. Dr. Clark has received several awards including the Marvin Johnson Award from the American Chemical Society (2006), the NorCal Chemical Engineering Excellence Award for Industrial Research (2004); the Food, Pharmaceutical, and Bioengineering Award from the American Institute of Chemical Engineers (2003); the International Enzyme Engineering Award (2003); and the Amgen Award in Biochemical Engineering (2003). In 2003 he was named a fellow of the American Association for the Advancement of Science, and in 1995 was elected a fellow of the American Institute of Medical and Biological Engineering.
Jonathan Dordick, Ph.D.
Cofounder and Technical Adviser
Jonathan S. Dordick is the Howard P. Isermann Professor of Chemical and Biological Engineering and Biology at Rensselaer Polytechnic Institute where he is also the Director of the Center for Biotechnology & Interdisciplinary Studies. He received his B.A. degree in Biochemistry and Chemistry from Brandeis University in 1980 and his Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology in 1986. He has held chemical engineering faculty appointments at the University of Iowa (1987-1998), where he also served as the Associate Director of the Center for Biocatalysis and Bioprocessing, and Rensselaer Polytechnic Institute (1998-present). Prof. Dordick has received numerous awards, including the 2007 Marvin J. Johnson Award, the 2007 Elmer Gaden Award, the 2003 International Enzyme Engineering Award, the 1998 Iowa Section Award of the American Chemical Society, and an NSF Presidential Young Investigator Award in 1989. He was elected as a Fellow of the American Association for the Advancement of Science in 2004 and a Fellow of the American Institute of Medical and Biological Engineering in 1996.
Rayton Gerald
Business Adviser
Rayton Gerald is a principal of the Company with primary responsibilities for business planning, strategy formulation, and business development. Mr. Gerald has more than 20 years experience working as either a principal or business advisor to owners and senior management of entrepreneurial companies. A graduate of the Harvard Business School and Howard University, he was senior vice president and a member of the executive committee of LM Capital Corporation.